Michael H Brave

2PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 04, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.

Michael H Brave, William F Maguire, Chana Weinstock

|Feb 01, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response.

Jaleh Fallah, Chana Weinstock, Gautam U Mehta

Pageof 1